Search

everythinglearnresearchcommunity

for

Search:↓

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Severe baldness on the top of the head is linked to a higher chance of heart disease, especially in men under 60.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

Sleep problems and skin issues affect each other; poor sleep can worsen skin conditions, and some skin treatments can improve or harm sleep quality.

Alopecia areata greatly affects people's life quality, mental health, and work life.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Genetic risk for PCOS can affect children's growth, metabolism, and development from early life into adulthood.

Mothers with alopecia areata have a higher risk of adverse birth outcomes.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Regular follow-up visits, especially with dermatologists, can lower death rates for melanoma patients, with socioeconomic factors also affecting outcomes.

Men on 5-alpha-reductase inhibitors might have worse COVID-19 outcomes.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Taking tamsulosin or finasteride and being older increase the risk of floppy iris during cataract surgery.

Dutasteride and finasteride have similar risk for osteoporosis and fractures in older men.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Taking 5 alpha reductase inhibitor medication slightly increases the risk of depression, especially as you get older.

People with autism are more likely to develop alopecia areata than those without autism.

Black and Hispanic women are more likely to have alopecia areata than white women.

The representation of skin conditions in medical reviews partly matches their real-world impact.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

High levels of testosterone and anti-Müllerian hormone before pregnancy are linked to a higher risk of newborns needing intensive care.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Women with PCOS have a similar chance of getting pregnant using assisted reproductive treatment as those without PCOS.

Vitamin D levels do not affect the risk of developing alopecia areata.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Men with high genetic risk for Polycystic Ovary Syndrome (PCOS) have increased chances of obesity, type 2 diabetes, heart disease, and hair loss, showing PCOS risk factors can affect both genders.

Hair loss greatly lowers perceived health in both genders, and hair transplant surgery notably improves this.